U.S. Industrial REITs Stock News

NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Newmark Group (NMRK) Plans A CEO Change, Is The Stock Still A Bargain?

Newmark Group (NMRK) has drawn fresh investor attention after announcing that long serving Chief Executive Officer Barry Gosin will step down on December 31, 2026, following decades in the role. See our latest analysis for Newmark Group. The CEO transition news comes after a mixed period for Newmark Group's stock, with the share price at US$15.25 and a share price return that is down 10.14% year to date but supported by a 3 year total shareholder return of 128.50%, which suggests that long...
NasdaqCM:AMPG
NasdaqCM:AMPGElectronic

AmpliTech Group (AMPG) Could Be 87% Undervalued As Q2 2026 Earnings Reset Sentiment

Why AmpliTech Group Stock Is Back In Focus After Q2 2026 Earnings AmpliTech Group (AMPG) is drawing fresh attention after its Q2 2026 earnings report showed lower sales and a wider net loss for both the quarter and the first half of the year. The company reported Q2 sales of US$8.07 million compared with US$11.03 million a year earlier, with net loss widening to US$3.09 million. For the first six months of 2026, sales were US$13.42 million versus US$14.63 million, while net loss increased to...
NYSE:SWX
NYSE:SWXGas Utilities

Southwest Gas Holdings (SWX) Returned To Profit, Is It Still A Bargain?

Southwest Gas Holdings (SWX) recently reported second quarter 2026 earnings that shifted from a net loss to a net profit year over year, while also reaffirming full year earnings guidance for continuing operations. See our latest analysis for Southwest Gas Holdings. The reaffirmed 2026 earnings guidance and move back to profitability appear to sit alongside strengthening market confidence in Southwest Gas Holdings, with a year to date share price return of 15.53% and a 3 year total...
NasdaqGM:MDWD
NasdaqGM:MDWDPharmaceuticals

MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips

MediWound walked into this print as a high-growth, high-expectation biotech, yet the stock barely moved, up just 0.04% on the day and still down over the past week, month and quarter. That flat reaction hides a more complicated headline. Q2 revenue came in at US$3.1m, while the company booked a net loss of US$7.4m, or US$0.57 per share, as spending on EscharEx Phase III work and NexoBrid scale-up pulled harder on the income statement. Is MediWound trading at a justifiable premium P/S of...
NasdaqCM:OTLK
NasdaqCM:OTLKBiotechs

Outlook Therapeutics (OTLK) Stock Looks Fully Valued While Book Value Stays Unclear

Outlook Therapeutics stock has had a very difficult five years, with the share price down about 98.3%, and the latest valuation checks currently do not flag the stock as a clear bargain despite this steep decline. Over the past five years, Outlook Therapeutics has declined around 98.3%, which means long term shareholders have seen most of their equity value eroded. The recent approval and planned U.S. launch of LYTENAVA, supported by a US$55 million equity offering, can help fund growth but...
NYSE:TDC
NYSE:TDCSoftware

Will Stronger EPS Guidance and New AWS AI Tools Change Teradata's (TDC) Narrative

In August 2026, Teradata Corporation reported past second-quarter 2026 results showing revenue of US$410 million and net income of US$46 million, alongside updated guidance calling for relatively flat full-year revenue but higher GAAP diluted EPS of US$4.43 to US$4.51. At the same time, Teradata pushed further into AI-enabled analytics with the launch of its Data Analyst Agent on Amazon Web Services Marketplace and added experienced technology executive Bernd Leukert to its expanded Board,...
NYSE:ARCO
NYSE:ARCOHospitality

Arcos Dorados (ARCO) Stock Slips As Record Margins Challenge Macro Fears

Arcos Dorados Holdings stock slipped about 3% to US$7.91 after the Q2 print, even though the quarter landed with record revenue of roughly US$1.3b and the highest adjusted earnings before interest, tax, depreciation and amortization in its history. You are watching a market that seems more focused on recent share price drift than on what was just put on the income statement. The real story in this earnings release sits in margins and cash generation. Profitability improved and adjusted free...
NasdaqGS:UFCS
NasdaqGS:UFCSInsurance

Stronger Profit Without Buybacks Might Change The Case For Investing In United Fire Group (UFCS)

In the past quarter, United Fire Group, Inc. reported second-quarter 2026 revenue of US$383.73 million and net income of US$33.37 million, with diluted EPS from continuing operations of US$1.29, while not repurchasing any shares between April 1 and June 30 under its long-running buyback program. These results capped a first half where both revenue and net income rose compared with the prior year, suggesting that improved operating performance rather than share repurchases has been the main...
NYSE:RBC
NYSE:RBCMachinery

RBC Bearings (RBC) Stock Looks Pricey As Its 156% Run Continues

RBC Bearings stock has delivered very strong share price gains over the past three years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a premium. RBC Bearings has returned 155.8% over the past three years, which puts extra focus on whether the current price still leaves much room for further value. The recent acquisition of PSC Couplings can support future cash flow growth, while any difficulty integrating new...
NYSE:A
NYSE:ALife Sciences

Agilent (A) Stock Looks Below Fair Value But Above Fair Value On Earnings

Agilent Technologies stock has delivered a 27.4% return over the past three years, while its valuation checks now show a split picture where the Discounted Cash Flow (DCF) intrinsic value points to upside and the market multiples look less generous. Over the past three years, Agilent Technologies returned 27.4%, which puts recent gains and today’s valuation in sharper focus for long term holders. The expanded EU approval for Agilent Technologies’ PD-L1 diagnostic test can support...
NYSE:DFIN
NYSE:DFINCapital Markets

How Donnelley Financial’s Shift Toward Subscription Software Could Impact Donnelley Financial Solutions (DFIN) Investors

Donnelley Financial Solutions recently advanced its transition toward a subscription-based model, emphasizing expanding software revenue streams to deepen client relationships and increase recurring income, a shift that has already occurred by today. This move highlights how Donnelley Financial is reshaping its business mix away from traditional services toward software-centric offerings, while accepting meaningful execution risk during the transformation. We’ll now examine how Donnelley...
NYSE:RL
NYSE:RLLuxury

Ralph Lauren (RL) Stock Looks Pricey On Returns Yet Fair On Earnings

Ralph Lauren stock has delivered a very strong 269.9% return over the past five years. However, current valuation checks suggest the shares now sit closer to fair value rather than looking clearly cheap. Ralph Lauren's 269.9% gain over five years highlights how much future growth and cash flow may already be reflected in the current share price. Recent revenue growth and margin expansion can support expectations for healthy cash generation. Any slowdown in demand or pressure on pricing would...
NYSE:AUB
NYSE:AUBBanks

Atlantic Union Bankshares (AUB), Why Is The Market Taking A Closer Look?

Atlantic Union Bankshares (AUB) has drawn investor interest after its recent share price performance, with the stock last closing at $42.88. This move has put a spotlight on how its banking business supports this valuation. See our latest analysis for Atlantic Union Bankshares. Looking beyond the latest move to $42.88, Atlantic Union Bankshares has shown building momentum, with a 90-day share price return of 18.03% and a 1-year total shareholder return of 32.72% supported by a 3-year total...
NasdaqGS:HTFL
NasdaqGS:HTFLHealthcare Services

HeartFlow (HTFL) Stock Rally Meets Widening Losses And Premium Valuation

HeartFlow stock exploded 35.7% higher to US$42.08 in the first full session after earnings. That is an emotional move for a company that still reports losses. The spark was not a one off headline. Q2 revenue reached US$64.1m and management lifted full year guidance to a range of US$246m to US$250m, which highlights the growth story investors have been paying up for. The key question now is whether this surge simply reflects the stronger fundamentals on display or stretches an already rich...
NYSE:FBP
NYSE:FBPBanks

Does First BanCorp’s (FBP) Richer Dividend Signal a New Balance Between Income and Growth?

Recently, First BanCorp announced that its annualized dividend has risen by 11.1%, lifting its dividend yield above the industry average and extending its record of consistent dividend growth. An interesting angle is how this richer dividend profile, coupled with projections for stronger earnings this fiscal year, may influence how investors view the bank’s income and growth mix. We’ll now explore how First BanCorp’s enhanced dividend growth story could reshape its existing investment...
NYSE:RRX
NYSE:RRXElectrical

Regal Rexnord (RRX) Moved Today, What Is Behind The Fresh Attention?

Regal Rexnord (RRX) is back in focus after its second quarter earnings and updated 2026 guidance highlighted a mixed picture for investors, with sector specific headwinds balanced by maintained adjusted EPS targets. See our latest analysis for Regal Rexnord. Regal Rexnord’s recent earnings update and narrowed 2026 GAAP EPS guidance have come against a softer share price backdrop. The stock fell 17.7% over the past month and 11.0% over the past quarter before a 2.9% one day rebound. The year...
NYSE:PRMB
NYSE:PRMBBeverage

Primo Brands (PRMB) Could Be 19% Undervalued On Its 20,000,000 Share Offering

Primo Brands (PRMB) has just completed a follow on equity offering of 20,000,000 Class A shares, raising about US$489.4 million at US$24.47 per share with a small discount. See our latest analysis for Primo Brands. Primo Brands shares are trading at US$24.70, with the stock showing a 4.79% 7 day share price gain and a 6.56% 90 day share price return, on top of a 52.56% year to date share price return. The 3 year total shareholder return of 77.16% contrasts with a more muted 2.81% total...
NYSE:AROC
NYSE:AROCEnergy Services

What Archrock (AROC)'s Profit Beat, Raised Guidance and M&A Ambitions Mean For Shareholders

In early August 2026, Archrock, Inc. reported second-quarter results showing higher net income of US$66.72 million year on year despite lower revenue, updated its full-year 2026 net income guidance to US$290.75 million–US$310.75 million, and highlighted capacity to pursue acquisitions alongside organic growth. An interesting twist for investors is that this improved profitability and acquisition appetite comes as analyst opinions diverge, with bullish brokerage ratings contrasting with a...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

Can SLM (SLM) Stay Below Fair Value After Its Q2 Miss?

SLM stock has more than doubled over the past three years, yet recent share price weakness and a strong overall value score suggest the market may still be pricing it cautiously. Over the last three years SLM has delivered a 108% return, which keeps longer term holders well ahead even though the past year has seen a 5.6% decline. Management focus on preparing for peak loan origination season and expanding products and partnerships can support earnings power, while higher noninterest expenses...
NYSE:MSC
NYSE:MSCHospitality

Studio City (MSC) Stock Price Rises Even As Losses Deepen

Studio City International stock inched 4.1% higher to US$1.80 after earnings, a modest bounce for a casino resort operator that many investors treat as a high risk value play. The headline is not the share price. The headline is that Q2 swung back to a loss, with basic earnings per share turning to a loss of US$0.08 and net income moving to a loss of US$15.6 million. That setback lands against a backdrop of lower valuation multiples and a long running effort to shrink losses. The rest of this...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Aveanna Healthcare (AVAH) Stock Climbs On Higher Guidance And Cash Flow

Aveanna Healthcare Holdings stock jumped about 9% to US$12.32 into the weekend, capping a strong run over the past month. That move came as the company posted Q2 revenue of US$670.5m and adjusted earnings before interest, tax, depreciation and amortisation of US$95.4m, and lifted full year guidance above US$2.68b of revenue and more than US$365m of adjusted EBITDA. For a home based care provider that lives and dies on contract rates, labour costs and leverage, the headline is simple: the...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Does Virgin Galactic Holdings (SPCE) Have Enough Value After Its 99% Fall?

Virgin Galactic Holdings has staged a short term rebound, yet the stock is still coming off a very steep multi year decline. This leaves investors weighing a recent rerating against what the current valuation checks actually say. Over the last 5 years the share price has declined about 99%, which puts the recent gains in the context of very heavy long term value destruction for shareholders. Strong demand for future spaceflight seats and expansion plans may support higher revenue...
NYSE:VICI
NYSE:VICISpecialized REITs

How Refinancing US$1.75 Billion Of 2026 Debt At VICI Properties (VICI) Has Changed Its Investment Story

VICI Properties Inc. has completed a US$1.75 billion public offering of senior unsecured notes via its subsidiary, VICI Properties L.P., issuing tranches due in 2031 and 2036 to help repay a portion of its senior notes maturing in 2026. This refinancing move reshapes VICI’s debt maturity profile and interest obligations, which can influence financial flexibility and risk perceptions among income-focused investors. Next, we’ll examine how refinancing US$1.75 billion of debt due in 2026 could...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

Diversified Healthcare Trust (DHC) Narrows Loss As Fair Value Narrative Stays Higher

Diversified Healthcare Trust (DHC) recently reported second quarter and six month 2026 results, with revenue lower than a year ago but a sharply smaller net loss, which highlights shifting fundamentals for investors to assess. See our latest analysis for Diversified Healthcare Trust. The latest earnings release has arrived after a strong period for Diversified Healthcare Trust, with the share price at $8.38 and a year-to-date share price return of 68.27%. The 1-year total shareholder return...